第一单位：
Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
作者：
C,Valenza [1]
;
D,Trapani [1]
;
F-C,Bidard [2]
;
J,Gligorov [3]
;
J,Cortés [4]
;
N,Turner [5]
;
F,Dalenc [6]
;
F,Penault-Llorca [7]
;
G,Freyer [8]
;
M,Arnedos [9]
;
C,Villanueva [10]
;
S,Loibl [11]
;
B,Pistilli [12]
;
G,Curigliano [13]
作者单位：
Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
[1]
Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France; Department of Medical Oncology, Université de Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France.
[2]
Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.
[3]
International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona; IOB Madrid, Hospital Beata Maria Ana, Madrid; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Oncoclínicas&Co, Jersey City, USA, Sao Paulo, Brazil.
[4]
Breast Cancer Now Research Centre, Institute of Cancer Research, London; Ralph Lauren Centre for Breast Cancer Research and Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK.
[5]
Department of Medical Oncology, Oncopole Claudius Regaud-IUCT, Inserm, Toulouse.
[6]
Department of Pathology and Biopathology, Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR 1240 INSERM-UCA, Clermont-Ferrand.
[7]
Department of Medical Oncology, HCL Cancer Institute, Lyon; Department of Medical Oncology, Lyon 1 University, Lyon.
[8]
Department of Medical Oncology Bordeaux, Institut Bergonié, Bordeaux.
[9]
Clinique Clémentville, Montpellier, France.
[10]
Center for Hematology and Oncology Bethanien, Frankfurt, Germany.
[11]
Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France.
[12]
Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
[13]
DOI
10.1016/j.esmoop.2024.103701
PMID
39232441
发布时间
2024-10-19
换一批
